BioSIM 抗人 CD309/VEGFR2 抗体 (阿拉赛

BioSIM 抗人 CD309/VEGFR2 抗体 (阿拉赛珠单抗)，生物类似药，科研用途

产品基本信息

英文名称：BioSIM anti-Human CD309/VEGFR2 Antibody (Alacizumab Biosimilar), Research Grade

产品货号：SIM0633-5mg

产品规格：5mg

供应商：InvivoCrown

CAS编号：934216-54-3

产品特性

产品类型：二抗

来源宿主：Humanized (人源化)

反应性：Human (人源)

背景资料

阿拉赛珠单抗是一种重组生物类似抗体，专为科研用途设计。该抗体在无动物成分的设施中生产，采用体外的无蛋白细胞培养技术，确保了产品的纯净度和一致性。

生产过程中包含多步骤纯化工艺，特别是采用Protein A或G的色谱技术，能够高效捕获目标抗体并去除杂质，为实验提供高质量的试剂。

研究领域：非小细胞肺癌（NSCLC）、转移性上皮癌

应用类型

本抗体适用于多种实验方法，包括：

• ELISA (酶联免疫吸附测定)
• FACS (流式细胞术)
• Functional assay (功能性实验)
• Research in vivo (体内研究)

技术参数

靶点：CD309/VEGFR2 (血管内皮生长因子受体2)，是血管生成过程中的关键受体，在肿瘤血管形成中发挥重要作用。

免疫原性：具体免疫原信息请参考产品说明书。

储存与稳定性

建议在-20°C条件下储存，避免反复冻融。使用前请平衡至室温，避免剧烈震荡。

科研应用价值

作为VEGFR2的靶向抗体，本产品可用于研究肿瘤血管生成机制、评估抗血管生成药物效果，以及探索非小细胞肺癌和转移性上皮癌的治疗新策略。

作为生物类似药，该抗体为研究者提供了高性价比的实验工具，可在基础研究和药物开发阶段替代原研抗体，降低研究成本同时保证实验结果的可靠性。

注意事项

本产品仅限科研用途，不可用于临床诊断或治疗。实验操作请遵循实验室安全规范，使用适当个人防护设备。

不同实验体系可能需要优化抗体浓度和实验条件，建议在使用前进行预实验确定最佳参数。

注意：以上信息可能随着产品优化升级等因素产生变动，具体信息请咨询亚科因公司。

BioSIM anti-Human CD309/VEGFR2 Antibody (Alacizumab Biosimilar), Research Grade

Product Basic Information

English Name: BioSIM anti-Human CD309/VEGFR2 Antibody (Alacizumab Biosimilar), Research Grade

Product Code: SIM0633-5mg

Product Specification: 5mg

Supplier: InvivoCrown

CAS Number: 934216-54-3

Product Characteristics

Product Type: Secondary Antibody

Source Host: Humanized

Reactivity: Human

Background Information

Alacizumab is a recombinant biosimilar antibody designed specifically for research purposes. This antibody is produced in an animal-component-free facility using in vitro protein-free cell culture technology, ensuring the purity and consistency of the product.

The production process includes multiple-step purification processes, especially the use of Protein A or G chromatography technology, which can efficiently capture the target antibody and remove impurities, providing high-quality reagents for experiments.

Research Areas: Non-Small Cell Lung Cancer (NSCLC), Metastatic Epithelial Carcinoma

Application Types

This antibody is suitable for a variety of experimental methods, including:

• ELISA (Enzyme-Linked Immunosorbent Assay)
• FACS (Flow Cytometry)
• Functional assay
• Research in vivo

Technical Parameters

Target: CD309/VEGFR2 (Vascular Endothelial Growth Factor Receptor 2), which is a key receptor in the angiogenesis process and plays an important role in tumor angiogenesis.

Immunogenicity: Please refer to the product manual for specific immunogenic information.

Storage and Stability

It is recommended to store at -20°C and avoid repeated freezing and thawing. Equilibrate to room temperature before use and avoid vigorous shaking.

Research Application Value

As a VEGFR2-targeted antibody, this product can be used to study the mechanism of tumor angiogenesis, evaluate the efficacy of anti-angiogenic drugs, and explore new treatment strategies for non-small cell lung cancer and metastatic epithelial carcinoma.

As a biosimilar, this antibody provides researchers with a cost-effective experimental tool. It can replace the original research antibody in basic research and drug development stages, reducing research costs while ensuring the reliability of experimental results.

Precautions

This product is for research purposes only and cannot be used for clinical diagnosis or treatment. Follow laboratory safety regulations during experimental operations and use appropriate personal protective equipment.

Optimization of antibody concentration and experimental conditions may be required for different experimental systems. It is recommended to conduct pre-experiments before use to determine the optimal parameters.

Note: The above information may change due to product optimization and upgrading. Please consult Yakeyin Company for specific information.